| Risk | High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.46% |
| NAV | ₹11.82 (29 Oct 2020) |
|---|---|
| Fund Started | 27 Jun 2018 |
| Fund Size | ₹264 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Suven Pharmaceutical Ltd. | Healthcare | Equity | 8.3% |
| Deepak Nitrite Ltd. | Chemicals | Equity | 6.9% |
| Neogen Chemicals Ltd. | Chemicals | Equity | 4.9% |
| Navin Fluorine International Ltd. | Chemicals | Equity | 4.2% |
| Vinati Organics Ltd. | Chemicals | Equity | 3.5% |
| Multi Commodity Exchange India | Financial | Equity | 3.5% |
| Kajaria Ceramics Ltd. | Construction | Equity | 3.4% |
| GMM Pfaudler Ltd. | Engineering | Equity | 3.4% |
| Zydus Wellness Ltd. | FMCG | Equity | 3.2% |
| Garware Technical Fibres Ltd. | Textiles | Equity | 2.8% |
L&T Emerging Opportunities Fund Series II Regular Dividend is a Equity Mutual Fund Scheme launched by L&T Mutual Fund. This scheme was made available to investors on 27 Jun 2018. Vihang Naik is the Current Fund Manager of L&T Emerging Opportunities Fund Series II Regular Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹264 Cr and the Latest NAV as of 29 Oct 2020 is ₹11.82.
The L&T Emerging Opportunities Fund Series II Regular Dividend is rated High risk. Minimum SIP Investment is set to 500.
The scheme seeks to provide capital appreciation by primarily investing in equity and equity related instruments of small cap companies